Literature DB >> 3345934

In vitro mucus glycoprotein production by colonic tissue from patients with ulcerative colitis.

G F Cope1, R V Heatley, J Kelleher, A T Axon.   

Abstract

Colonic mucus production was measured in vitro by means of incorporation of tritiated glucosamine using biopsy material from patients with ulcerative colitis and compared with data from patients with Crohn's disease, colonic carcinoma, colonic polyps and patients with apparently normal colonic mucosae. Mucus production was significantly decreased (p less than 0.03) in all patients with ulcerative colitis, and in particular in patients with inactive disease when compared with normal subjects. In patients with active disease mucus production was not significantly different from normal subjects. The radiolabelled material was characterised by gel filtration and ion exchange liquid chromatography as mainly high molecular weight glycoproteins. These results indicate that the quantitative character of colonic mucus is abnormal in inactive ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345934      PMCID: PMC1433306          DOI: 10.1136/gut.29.2.229

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Proceedings: Changes in human colonic mucus in ulcerative colitis.

Authors:  G M Fraser; J R Clamp
Journal:  Gut       Date:  1975-10       Impact factor: 23.059

2.  The action of proteolytic enzymes on the glycoprotein from pig gastric mucus.

Authors:  M Scawen; A Allen
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

3.  Smoking and colonic mucus in ulcerative colitis.

Authors:  G F Cope; R V Heatley; J K Kelleher
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

4.  Changes in monosaccharide content of mucous glycoproteins in ulcerative colitis.

Authors:  R H Teague; D Fraser; J R Clamp
Journal:  Br Med J       Date:  1973-06-16

5.  Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis.

Authors:  G L Eastwood; J S Trier
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

6.  Synthesis of intestinal glycoprotein. Incorporation of (I- 14 C) glucosamine in vitro.

Authors:  B E Lukie; G G Forstner
Journal:  Biochim Biophys Acta       Date:  1971-02-28

7.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

8.  Histochemistry of the colonic epithelial mucins in normal subjects and in patients with ulcerative colitis. A qualitative and histophotometric investigation.

Authors:  V Greco; G Lauro; A Fabbrini; A Torsoli
Journal:  Gut       Date:  1967-10       Impact factor: 23.059

9.  Glycoprotein synthesis and secretion by mucosal biopsies of rabbit colon and human rectum.

Authors:  R P MacDermott; R M Donaldson; J S Trier
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

10.  Stimulation of colonic glycoprotein synthesis by dibutyryl cyclic AMP and theophylline.

Authors:  J T LaMont; A Ventola
Journal:  Gastroenterology       Date:  1977-01       Impact factor: 22.682

View more
  11 in total

1.  An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants.

Authors:  Jenny K Gustafsson; Anna Ermund; Malin E V Johansson; André Schütte; Gunnar C Hansson; Henrik Sjövall
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-08       Impact factor: 4.052

Review 2.  Cigarette smoking and intestinal defences.

Authors:  G F Cope; R V Heatley
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

3.  In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy.

Authors:  Hao Ding; Andrew W Dupont; Shashideep Singhal; Larry D Scott; Sushovan Guha; Mamoun Younes; Xiaohong Bi
Journal:  Biomed Opt Express       Date:  2017-06-23       Impact factor: 3.732

4.  Characterization of mucin in whole-gut lavage fluid obtained from patients with inflammatory bowel disease.

Authors:  H Saitoh; K Takagaki; T Nakamura; A Munakata; Y Yoshida; M Endo
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

5.  Mucin depletion in inflammatory bowel disease.

Authors:  D A McCormick; L W Horton; A S Mee
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

Review 6.  Colonic mucus and mucosal glycoproteins: the key to colitis and cancer?

Authors:  J M Rhodes
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

7.  South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover.

Authors:  C S Probert; B F Warren; T Perry; E H Mackay; J F Mayberry; A P Corfield
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

8.  Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect.

Authors:  A Raouf; N Parker; D Iddon; S Ryder; B Langdon-Brown; J D Milton; R Walker; J M Rhodes
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

9.  Effects of Yersinia enterocolitica infection on rabbit intestinal and colonic goblet cells and mucin: morphometrics, histochemistry, and biochemistry.

Authors:  M Mantle; E Atkins; J Kelly; E Thakore; A Buret; D G Gall
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  Colonic mucin synthesis is increased by sodium butyrate.

Authors:  I A Finnie; A D Dwarakanath; B A Taylor; J M Rhodes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.